BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Surgery

A Meta-Analysis of Apolipoprotein E Gene e2/e3/e4 Polymorphism for Gallbladder Stone Disease
Published: Tuesday, September 25, 2012
Author: Pei Xue et al.

by Pei Xue, Wen-Quan Niu, Zhao-Yan Jiang, Min-Hua Zheng, Jian Fei

Background

Numerous studies have investigated the relationship between apolipoprotein (Apo) E gene polymorphisms and gallbladder stone disease (GSD) across ethnic populations; however, the results are often inconsistent. This meta-analysis aims to comprehensively evaluate the influence of a common e2/e3/e4 polymorphism in Apo E gene on the risk of gallbladder stone disease.

Method

Data were analyzed using the RevMan software (V5.1) and a random-effects model was applied irrespective of between-study heterogeneity. Publication bias was weighed using the fail-safe number.

Results

There were 17 study populations totaling 1773 cases and 2751 controls for e2/e3/e4 polymorphism of Apo E gene. Overall comparison of alleles e2 with e3 in all study populations yielded a 16% decreased risk for GSD (95% confidence interval [95% CI]: 0.68–1.05; P?=?0.31; I2?=?13%), and comparison of alleles e4 with e3 yielded a 25% increased risk (95% confidence interval [95% CI]: 0.97–1.61; P?=?0.0003; I2?=?63%). Subgroup analysis by study design indicated that the magnitude of association in hospital-based studies was largely significantly strengthened for e4 allelic model (odds ratio [OR] ?=?1.46; 95% CI: 1.05–2.02; p?=?0.0007; I2?=?65%). Subgroup analysis by age of controls indicated a remarkably significant elevation in the magnitude of association in age >50 subgroups in e4 allelic model (OR?=?1.50; 95% CI: 1.03–2.19; p?=?0.0009; I2?=?72%). Moreover, subgroup analysis by cases gender indicated a reduction in the magnitude of association in male<30% studies for E2/2 genotypic model (OR?=?0.32; 95% CI: 0.07–1.49; p?=?0.16; I2?=?45%).

Conclusions

Our results reveal that Apo E gene e4 allele is a risk factor of gallbladder stone disease, especially in elder people and Chinese population.

  More...

 

//-->